From Data to Evidence: March 2024 Biologit Newsletter
Welcome to From Data to Evidence, our newsletter with the latest industry and regulatory news in pharmacovigilance and technology
Our latest white paper on Literature Monitoring Challenges and Opportunities is out. Get it here!